Discover how immune checkpoint blockers are revolutionizing the treatment of leukemia and lymphoma by re-arming the body's own T-cells to fight cancer.
Exploring the role of CCL18/CCR6 axis in fibrosis and cancer progression, and how blocking this signaling pathway could lead to new treatments.
Exploring the paradoxical role of ERBB3 (HER3) in cancer biology and its context-dependent effects on treatment response.
Exploring how nanocarriers are revolutionizing immune cell engineering for more effective and affordable cancer treatments.
Explore how engineered antibodies are revolutionizing cancer treatment through precision targeting, immune activation, and advanced biotechnologies.
Exploring how machine learning is revolutionizing our understanding of TERT expression in cancer cells and its implications for precision oncology.